156 related articles for article (PubMed ID: 34622843)
1. Efficacy of intravitreal dexamethasone implant in patients with Vogt-Koyanagi-Harada Disease and bilateral panuveitis: Two case reports.
Chen PL; Chen SN
Medicine (Baltimore); 2021 Oct; 100(40):e27394. PubMed ID: 34622843
[TBL] [Abstract][Full Text] [Related]
2. Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis.
Latronico ME; Rigante D; Caso F; Cantarini L; Costa L; Nieves-Martín L; Traversi C; Franceschini R
Clin Rheumatol; 2015 Jun; 34(6):1145-8. PubMed ID: 24763751
[TBL] [Abstract][Full Text] [Related]
3. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.
Elhamaky TR
Indian J Ophthalmol; 2022 Jul; 70(7):2465-2470. PubMed ID: 35791135
[TBL] [Abstract][Full Text] [Related]
5. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
6. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
Chew SK; Levy J; Rogers S; Lim LL
Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
[TBL] [Abstract][Full Text] [Related]
8. Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
Perente I; Utine CA; Cakir H; Kaya V; Tutkun IT; Yilmaz OF
Int Ophthalmol; 2009 Feb; 29(1):33-7. PubMed ID: 17952373
[TBL] [Abstract][Full Text] [Related]
9. Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
Soheilian M; Aletaha M; Yazdani S; Dehghan MH; Peyman GA
Ocul Immunol Inflamm; 2006 Apr; 14(2):91-8. PubMed ID: 16597538
[TBL] [Abstract][Full Text] [Related]
10. [Vogt-Koyanagi-Harada syndrome (clinical cases)].
Sorokin EL; Voronina NV; Avramenko SY; Pomytkina NV
Vestn Oftalmol; 2015; 131(3):90-98. PubMed ID: 26310014
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
Park HS; Nam KY; Kim JY
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
[TBL] [Abstract][Full Text] [Related]
12. A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab.
Su E; Oza VS; Latkany P
J Formos Med Assoc; 2019 May; 118(5):945-950. PubMed ID: 30616991
[TBL] [Abstract][Full Text] [Related]
13. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
Yamaguchi Y; Otani T; Kishi S
Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
[TBL] [Abstract][Full Text] [Related]
14. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease.
Yamamoto N; Naito K
Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715
[TBL] [Abstract][Full Text] [Related]
15. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
Ishihara K; Hangai M; Kita M; Yoshimura N
Ophthalmology; 2009 Sep; 116(9):1799-807. PubMed ID: 19643489
[TBL] [Abstract][Full Text] [Related]
16. [Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].
Tian S; Yao J; Wang J; Zhang J; Zhou A
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):135-140. PubMed ID: 33509766
[TBL] [Abstract][Full Text] [Related]
17. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
18. Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome.
Ranjan R; Agarwal M
Indian J Ophthalmol; 2018 Jun; 66(6):863-865. PubMed ID: 29786006
[TBL] [Abstract][Full Text] [Related]
19. [Vogt-Koyanagi-Harada disease].
Kjeka O; Krohn J
Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography/computed tomography scan of Vogt-Koyanagi-Harada syndrome with associated autoimmune thyroid disease: A case report and literature review.
Huang KH; Tai MC; Lee LC; Weng TH; Chen YH; Lin LF; Chen JT; Lu DW; Chen CL
Medicine (Baltimore); 2018 Mar; 97(9):e0047. PubMed ID: 29489658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
